Proportion of Patients (%) with Undetectable Levels of Virus (<15 IU/mL) by Week | |||||||||
Week 1 | Week 2 | Week 3 | Week 4 | Week 6 | Week 8 | Week 10 | Week 12 | ||
ANA598 + SOC 200 mg bid | 11 | 22 | 44 | 56 | 65 | 69 | 73 | 73 | |
ANA598 + SOC 400 mg bid | 9 | 27 | 30 | 42 | 56 | 72 | 75 | 75 | |
Placebo + SOC | 0 | 3 | 9 | 13 | 19 | 38 | 48 | 63 | |
